Cholesterol, inflammation, and phospholipids: COVID-19 share traits with cardiovascular disease.

Pimentel, Lígia L; Rodríguez-Alcalá, Luis M

Pimentel, Lígia L; Rodríguez-Alcalá, Luis M.

Pimentel LL; Universidade Católica Portuguesa, CBQF - Centro de Biotecnologia e Química Fina - Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal. Electronic address: lpimentel@porto.ucp.pt.
Rodríguez-Alcalá LM; Universidade Católica Portuguesa, CBQF - Centro de Biotecnologia e Química Fina - Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal. Electronic address: lalcala@porto.ucp.pt.

Biochim Biophys Acta Mol Cell Biol Lipids ; 1866(1): 158839, 2021 01.

Article in English | MEDLINE | ID: covidwho-866433

Subject(s)

COVID-19/metabolism; Cardiovascular Diseases/metabolism; Cholesterol/metabolism; Phospholipids/metabolism; Angiotensin-Converting Enzyme 2/metabolism; Biomarkers/metabolism; COVID-19/immunology; COVID-19/pathology; Cardiovascular Diseases/immunology; Cardiovascular Diseases/pathology; Humans; Inflammation; Membrane Microdomains/metabolism; Phospholipids/immunology; SARS-CoV-2

Keywords

Antiphospholipid syndrome; Cholesterol; Covid-19; LDL; Lipid rafts; Omega 3 fatty acids; Phospholipids; S1P

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Phospholipids / Cardiovascular Diseases / Cholesterol / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Biochim Biophys Acta Mol Cell Biol Lipids Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google